Free Trial
ASX:HLS

Healius (HLS) Stock Price, News & Analysis

Healius logo

About Healius Stock (ASX:HLS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.33 million shs
Average Volume
N/A
Market Capitalization
A$1.01 billion
P/E Ratio
N/A
Dividend Yield
4.46%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HLS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Healius and its competitors with MarketBeat's FREE daily newsletter.

HLS Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Spheria Reduces Stake in Healius Limited
See More Headlines

HLS Stock Analysis - Frequently Asked Questions

Healius Limited (ASX:HLS) announced its earnings results on Friday, February, 15th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.09 by $0.06. Healius had a negative net margin of 36.98% and a negative trailing twelve-month return on equity of 61.77%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Healius investors own include bluebird bio (BLUE), Argonaut Gold (AR), Athene (ATH), BELLUS Health (BLU), Esperion Therapeutics (ESPR), Fortress Biotech (FBIO) and Forte Biosciences (FBRX).

Company Calendar

Last Earnings
2/15/2019
Ex-Dividend for 5/22 Dividend
5/08/2025
Record date for 5/22 Dividend
5/22/2025
Dividend Payable
5/22/2025
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
ASX:HLS
CIK
N/A
Fax
N/A
Employees
10,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.96)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-0.94
Net Income
-A$636 million
Net Margins
-36.98%
Pretax Margin
N/A
Return on Equity
-61.77%
Return on Assets
1.23%

Debt

Debt-to-Equity Ratio
153.54
Current Ratio
0.50
Quick Ratio
0.47

Sales & Book Value

Annual Sales
A$1.75 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
12.26
Book Value
A$0.88 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
726,130,000
Free Float
N/A
Market Cap
A$1.01 billion
Optionable
Not Optionable
Beta
0.73
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (ASX:HLS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners